IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q2 2018 Holdings

Filed 2018-08-14 | 27 holdings | $323.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$282.1M4,240,53687.2%
Biocryst Pharmaceuticals(BCRX)COM09058V103$40.0M6,984,69212.4%
Wave Life Sciences LTD(WVE)SHSY95308105$287.3K7,512,0490.1%
Solid Biosciences IncCOM83422E105$95.8K2,689,4440.0%
Endocyte IncCOM29269A102$78.0K5,649,8840.0%
Momenta Pharmaceuticals Inc(MNTA)COM60877T100$75.7K3,702,5330.0%
Immunomedics Inc(IMMU)COM452907108$73.8K3,119,7780.0%
Myovant Sciences LTDCOMG637AM102$64.7K2,830,4550.0%
Inflarx NV(IFRX)COMN44821101$63.4K1,967,1480.0%
TG Therapeutics Inc(TGTX)COM88322Q108$56.3K4,278,7960.0%
Sage Therapeutics Inc(SG7)COM78667J108$54.9K350,9330.0%
Zogenix IncCOM NEW98978L204$50.6K1,145,2680.0%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$48.2K1,541,7430.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$48.2K3,933,4890.0%
Eidos Therapeutics Inc(EIDXGBP)COM28249H104$44.0K2,162,6710.0%
RA Pharmaceuticals IncCOM74933V108$38.3K3,851,8080.0%
Kala Pharmaceuticals IncCOM483119103$29.0K2,113,2360.0%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$19.8K900,0000.0%
Clearside Biomedical Inc(CLSDUSD)COM185063104$16.3K1,525,0000.0%
Scpharmaceuticals Inc(SCPH)COM810648105$16.2K2,857,1430.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$14.4K1,121,1530.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$11.7K1,441,0700.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$11.4K5,062,7590.0%
Spero Therapeutics Inc(SPRO)COM84833T103$10.9K741,6470.0%
Glycomimetics Inc(GLYCEUR)COM38000Q102$4.1K253,5470.0%
Proteon Therapeutics IncCOM74371L109$3.3K1,337,4620.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$1.7K40,0000.0%